amoxapine has been researched along with Cancer of Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, T; Kang, J; Kong, X; Li, X; Liu, H; Rong, D; Song, G; Sun, G; Tang, W; Wang, K; Xia, Y; Zhang, Z; Zheng, Z | 1 |
1 other study(ies) available for amoxapine and Cancer of Liver
| Article | Year |
|---|---|
Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.
Topics: Amoxapine; B7-H1 Antigen; Carcinoma, Hepatocellular; Glucuronidase; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor | 2022 |